Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 23

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 23
---
 Notices on a particular related VWAP Purchase
Date and/or Additional VWAP Purchase Date require a payment from the Investor that exceeds $2,500,000, unless such limitation is waived
by the Investor in its sole discretion as to any single or combination of VWAP Purchase Notices and/or Additional VWAP Purchase Notices
on a particular related VWAP Purchase Date and/or Additional VWAP Purchase Date.

(h) . With respect to each Fixed Purchase Notice, VWAP Purchase Notice and/or Additional VWAP Purchase Notice, the Company
shall deliver to the Investor a completed form of purchase notice in materially the form attached hereto as .

| -10- |

3. INVESTOR’S REPRESENTATIONS AND WARRANTIES.

The Investor represents and
warrants to the Company that as of the date hereof and as of the Commencement Date:

(a) . Investor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization,
with the requisite power and authority to enter into and to consummate the transactions contemplated by this Agreement and the Registration
Rights Agreement and otherwise to carry out its obligations hereunder and thereunder.

(b) . The Investor is acquiring the Securities as principal for its own account, for investment purposes, and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other Persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
the Investor’s right to sell the Securities at any time pursuant to the Registration Statement described herein or otherwise in
compliance with applicable federal and state securities laws). The Investor is acquiring the Securities hereunder in the ordinary
course of its business.

(c) . The Investor is an “accredited investor” as that term is defined in Rule 501(a)(3) of Regulation D promulgated
under the Securities Act.

(d) . The Investor understands that the Securities are being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of